We’re thrilled to bring you the latest insights into ME/CFS research through an exclusive interview led by advocate and caregiver Janet Dafoe, Ph.D. Today, Ron Davis, Ph.D., OMF Scientific Advisory Board Director, sits down to discuss his most recent publication: “Catalytic Antibodies May Contribute to Demyelination in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.” Access the full publication here.
Immerse yourself in the conversation and gain access to the latest in ME/CFS research.
Help us Spread the Word! Leave a Review for OMF on GreatNonprofits.org!
As you know, OMF is dedicated to driving innovative research and development of treatments for ME/CFS, Long COVID and similar diseases.
One way we can continue to raise awareness and support for our mission is through online reviews on reputable platforms such as GreatNonprofits.org. We would be grateful if you could take a few minutes to leave a review of your experience with OMF.
(Click on the “Share your story” button to give your feedback.)
By sharing your thoughts, you can help others understand the impact of the research OMF funds and how it has touched your life. Your review will also help us continue to attract more people to the OMF community.
Thank you for your continued support of our mission and for helping to spread the word about our work.
Donate your appreciated stock directly to OMF and you can receive an immediate income-tax deduction for the fair market value of the securities on the date of transfer (even if you originally paid much less for them).